证券代码：603077 证券简称：和邦生物 公告编号：2025-045 债券代码：113691 债券简称：和邦转债 四川和邦生物科技股份有限公司 关于可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、可转债本次转股情况 （一）"和邦转债"转股期自 2025 年 5 月 6 日起至 2030 年 10 月 27 日止。 截至 2025 年 9 月 30 日，累计转股金额为 282,000 元，累计因转股形成的股份数 量 141,000 股，占可转债转股前公司已发行股份总额的 0.0016%。其中，2025 年 7 月 1 日至 2025 年 9 月 30 日，"和邦转债"转股金额为 53,000 元，因转股形 成的股份数量 26,500 股。 重要内容提示： ● 累计转股情况：截至 2025 年 9 月 30 日，四川和邦生物科技股份有限公 司（以下简称"公司"、"本公司"）可转债"和邦转债"累计转股金额为 282,000 元，累计因转股形成的股份数量 141,000 股，占可转债转股前公司已发行 ...

| | | 被担保人名称 | | 武骏重庆光能有限公司 | | | --- | --- | --- | --- | --- | --- | | | 保 对 | 本次担保金额 | 20,000.00 | 万元 | | | 担 象 | | 实际为其提供的担保余额 | 115,268.92 | 万元 | | | | | 是否在前期预计额度内 | 是 | □否 | □不适用：_________ | | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 | 766,306.65 | | 子公司对外担保总额（万元） | | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 41.14 | | | □对外担保总额（含本次）超过上市公司最 近一期经审计净资产 50% | | | □对外担保总额（含本次）超过上市公司最 | | | 近一期经审计净资产 100% | | 特别风险提示（如有请勾选） | □对合并报表外单位担保总额（含本次）达 | | | ...

Core Viewpoint - The Shanghai Composite Index has surged past the 3900-point mark, reaching its highest level since August 2015, driven by a significant rise in gold prices and increased gold reserves by the People's Bank of China [1] Market Performance - On October 9, the Shanghai Composite Index opened high and continued to rise, breaking the 3900-point threshold [1] - The ChiNext Index and the STAR 50 Index experienced fluctuations, with a notable surge in the gold sector, where nearly 20 stocks, including Zhejiang Fortune Holdings and Shandong Gold, hit the daily limit [1] Gold Market Dynamics - During the National Day holiday, spot gold prices continued to rise, reaching a historic high, with prices surpassing $4000 per ounce on October 8 [1] - As of the end of September, China's gold reserves stood at 74.06 million ounces, reflecting an increase of 40,000 ounces month-on-month, marking the 11th consecutive month of gold accumulation by the central bank [1] Economic Influences - According to CITIC Securities, expectations of interest rate cuts by the Federal Reserve and concerns over the U.S. economy's downturn have heightened global investor anxiety regarding the credibility of the U.S. dollar and sovereign debt, further driving up the prices of precious metals [1] - Additionally, a supply shortage and the logic of a computing power revolution have contributed to a noticeable increase in copper prices recently [1]

2025年9月23日，四川和邦生物科技股份有限公司与成都银行重庆分行签订《最高额保证合同》，为控 股子公司武骏重庆光能有限公司提供2亿元连带责任保证，保证期间三年，无反担保。此次担保在前期 预计额度内，公司此前已通过相关授权议案。截至公告日，和邦生物及其控股子公司对外担保总额 76.63亿元，占最近一期经审计净资产的41.14%，无逾期担保情况。公司称此次担保符合整体利益和发 展战略，风险可控。 ...

Report Summary - The report presents the top ten convertible bonds for October 2025, along with an analysis of the issuing companies, including their business profiles, financial performance, and key attractions [13][23][35] Top Ten Convertible Bonds in October 2025 1. Zhongte Convertible Bond - Rating: AAA; 9 - month - end closing price: 112.896 yuan; Conversion premium rate: 85.92%; PE - TTM of the underlying stock: 13.22 [7][13] - Company: A globally leading specialized special - steel material manufacturer with a production capacity of about 20 million tons of special - steel materials per year. It has multiple production and raw - material bases, forming a strategic layout along the coast and rivers [13] - Financials: In 2024, revenue was 109.203 billion yuan (YoY - 4.22%), net profit attributable to shareholders was 5.126 billion yuan (YoY - 10.41%). In H1 2025, revenue was 54.715 billion yuan (YoY - 4.02%), net profit attributable to shareholders was 2.798 billion yuan (YoY + 2.67%) [13] - Key attractions: It is one of the world's most comprehensive special - steel enterprises in terms of variety and specification, with leading cost - control ability and potential for external expansion [14] 2. Shanlu Convertible Bond - Rating: AAA; 9 - month - end closing price: 119.346 yuan; Conversion premium rate: 48.74%; PE - TTM of the underlying stock: 4.08 [7][23] - Company: Mainly engaged in road and bridge construction and maintenance, and also expanding into other fields. It can provide one - stop comprehensive services [23] - Financials: In 2024, revenue was 71.348 billion yuan (YoY - 2.3%), net profit attributable to shareholders was 2.322 billion yuan (YoY + 1.47%). In H1 2025, revenue was 28.575 billion yuan (YoY + 0.26%), net profit attributable to shareholders was 1.029 billion yuan (YoY + 0.89%) [23] - Key attractions: It has the concept of "China - specific valuation", potential for improvement in various aspects under the debt - resolution background, and opportunities from regional infrastructure construction and the Belt and Road Initiative [24] 3. Hebang Convertible Bond - Rating: AA; 9 - month - end closing price: 126.41 yuan; Conversion premium rate: 21.55%; PE - TTM of the underlying stock: - 168.47 [7][35] - Company: With advantages in mineral resources and gas supply, it has completed a basic layout in the chemical, agricultural, and photovoltaic fields [35] - Financials: In 2024, revenue was 8.547 billion yuan (YoY - 3.13%), net profit attributable to shareholders was 31 million yuan (YoY - 97.55%). In H1 2025, revenue was 3.921 billion yuan (YoY - 19.13%), net profit attributable to shareholders was 52 million yuan (YoY - 73.07%) [35] - Key attractions: Its phosphate mines and salt mines have good profit - making potential, and the liquid methionine business is a major profit contributor [36] 4. Aima Convertible Bond - Rating: AA; 9 - month - end closing price: 128.513 yuan; Conversion premium rate: 38.62%; PE - TTM of the underlying stock: 13.41 [7][45] - Company: The leading enterprise in the electric two - wheeled vehicle industry, mainly engaged in R & D, production, and sales of electric two - wheeled vehicles [45] - Financials: In 2024, revenue was 21.606 billion yuan (YoY + 2.71%), net profit attributable to shareholders was 1.988 billion yuan (YoY + 5.68%). In H1 2025, revenue was 13.031 billion yuan (YoY + 23.04%), net profit attributable to shareholders was 1.213 billion yuan (YoY + 27.56%) [45] - Key attractions: It may benefit from government subsidies, new national standards, and potential improvement in gross margin [46] 5. Xingye Convertible Bond - Rating: AAA; 9 - month - end closing price: 120.859 yuan; Conversion premium rate: 29.02%; PE - TTM of the underlying stock: 5.43 [7][54] - Company: One of the first joint - stock commercial banks in China, evolving into a modern financial service group [54] - Financials: In 2024, revenue was 212.226 billion yuan (YoY + 0.66%), net profit attributable to shareholders was 77.205 billion yuan (YoY + 0.12%). In H1 2025, revenue was 110.458 billion yuan (YoY - 2.29%), net profit attributable to shareholders was 43.141 billion yuan (YoY + 0.21%) [54] - Key attractions: It has stable asset quality and scale growth [55] 6. Wentai Convertible Bond - Rating: AA -; 9 - month - end closing price: 128.918 yuan; Conversion premium rate: 20.93%; PE - TTM of the underlying stock: - 23.14 [7][66] - Company: A globally leading semiconductor enterprise adopting the IDM model, providing R & D, manufacturing, and testing services [66] - Financials: In 2024, revenue was 73.598 billion yuan (YoY + 20.23%), net profit attributable to shareholders was - 2.833 billion yuan (YoY - 339.83%). In H1 2025, revenue was 25.341 billion yuan (YoY - 24.56%), net profit attributable to shareholders was 474 million yuan (YoY + 237.36%) [66] - Key attractions: After focusing on the semiconductor business, it benefits from market recovery and has growth potential in the automotive and consumer electronics fields [67] 7. Chongyin Convertible Bond - Rating: AAA; 9 - month - end closing price: 121.778 yuan; Conversion premium rate: 31.87%; PE - TTM of the underlying stock: 5.88 [7][77] - Company: An early local joint - stock commercial bank in the upper reaches of the Yangtze River and Southwest China, with a wide range of business scopes [77] - Financials: In 2024, revenue was 13.679 billion yuan (YoY + 3.54%), net profit attributable to shareholders was 5.117 billion yuan (YoY + 3.8%). In H1 2025, revenue was 7.659 billion yuan (YoY + 7%), net profit attributable to shareholders was 3.19 billion yuan (YoY + 5.39%) [77] - Key attractions: It can benefit from the development of the Chengdu - Chongqing economic circle, has stable asset - scale growth, and effective risk - control strategies [78] 8. Tianye Convertible Bond - Rating: AA +; 9 - month - end closing price: 120.562 yuan; Conversion premium rate: 48.06%; PE - TTM of the underlying stock: 146.42 [7][89] - Company: A leading enterprise in the chlor - alkali chemical industry in Xinjiang, with an integrated circular economy industrial chain [89] - Financials: In 2024, revenue was 11.156 billion yuan (YoY - 2.7%), net profit attributable to shareholders was 68 million yuan (YoY + 108.83%). In H1 2025, revenue was 5.16 billion yuan (YoY - 0.98%), net profit attributable to shareholders was - 9 million yuan (YoY - 228.22%) [89] - Key attractions: It may benefit from the price change of caustic soda and has plans for dividend increase and coal - mine projects [90] 9. Aorui Convertible Bond - Rating: AA -; 9 - month - end closing price: 126.412 yuan; Conversion premium rate: 40.56%; PE - TTM of the underlying stock: 22.72 [7][100] - Company: A company focusing on the R & D, production, and sales of complex APIs and preparations, with leading positions in multiple fields [100] - Financials: In 2024, revenue was 1.476 billion yuan (YoY + 16.89%), net profit attributable to shareholders was 355 million yuan (YoY + 22.59%). In H1 2025, revenue was 822 million yuan (YoY + 12.5%), net profit attributable to shareholders was 235 million yuan (YoY + 24.55%) [100] - Key attractions: It has a growing dealer network, expanding preparation products, and high - quality customer resources [101] 10. Yushui Convertible Bond - Rating: AAA; 9 - month - end closing price: 125.081 yuan; Conversion premium rate: 30.74%; PE - TTM of the underlying stock: 26.93 [7][108] - Company: The largest integrated water supply and drainage enterprise in Chongqing, with a stable monopoly position [108] - Financials: In 2024, revenue was 6.999 billion yuan (YoY - 3.52%), net profit attributable to shareholders was 785 million yuan (YoY - 27.88%). In H1 2025, revenue was 3.519 billion yuan (YoY + 7.16%), net profit attributable to shareholders was 458 million yuan (YoY + 10.06%) [108] - Key attractions: It has a high market share, is expanding business externally, and has effective cost - control measures [109]

Core Viewpoint - The Shanghai Composite Index has surpassed the 3900-point mark, indicating a bullish trend in the market, particularly in the chemical sector, driven by the elimination of outdated production capacity and improved industrial profits [1] Group 1: Market Performance - The Shanghai Composite Index continued its upward trend in the afternoon session, breaking the 3900-point threshold [1] - The China Securities Index for the petrochemical industry rose approximately 2.4%, with significant gains in constituent stocks such as Hangzhou Oxygen Plant, Hebang Biotechnology, and Yilong Lake [1] - The Petrochemical ETF (159731) followed the index's upward movement [1] Group 2: Industry Insights - Guosen Securities anticipates that the implementation of outdated capacity elimination will optimize the supply side of the chemical industry, enhancing overall competitiveness [1] - In August, the total profit of industrial enterprises above designated size increased by 20.4% year-on-year, a significant turnaround from July's -1.5%, signaling stabilization in the industrial economy [1] - The growth in profits is attributed to a low base from the previous year and effective macroeconomic policies, particularly the "anti-involution" measures that have regulated competition and stabilized industrial prices [1] Group 3: ETF and Sector Composition - The Petrochemical ETF (159731) and its linked funds (017855/017856) closely track the China Securities Index for the petrochemical industry [1] - The basic chemical industry accounts for 61.93% of the sector distribution, while the oil and petrochemical industry represents 30.84% [1] - The top ten weighted stocks in the index include Wanhua Chemical, China Petroleum, and Yilong Lake, collectively accounting for 55.12% of the total weight [1]

Core Viewpoint - The trading volume of Hebang Biotechnology reached 1.37 billion yuan, marking a new high since December 9, 2024, with the latest stock price increasing by 9.13% and a turnover rate of 6.95% [1] Summary by Categories - **Trading Performance** - Hebang Biotechnology's trading volume hit 1.37 billion yuan, the highest since December 9, 2024 [1] - The stock price rose by 9.13% [1] - The turnover rate was recorded at 6.95% [1]

Group 1 - The chemical sector is experiencing significant growth, with the chemical ETF (516020) showing a price increase of 1.72% at close, marking five consecutive days of gains [1] - Key stocks in the sector include companies like Hebang Bio and Xinzhou Bang, which saw increases of over 6%, while Shengquan Group and Duofuduo rose over 5% [1] - The sub-sector index for fine chemicals has shown a cumulative increase of 26.84% in Q3, outperforming major A-share indices such as the Shanghai Composite Index (12.73%) and the CSI 300 Index (17.9%) [4] Group 2 - East China Securities suggests that the chemical industry may see profit recovery due to regulatory controls on outdated production capacity and the ongoing "anti-involution" efforts [2][6] - Investment opportunities are identified in sectors benefiting from self-regulation and policy guidance, such as polyester filament, organic silicon, and pesticides [3] - The chemical ETF (516020) has a price-to-book ratio of 2.31, indicating a favorable long-term investment value [5] Group 3 - The chemical industry is expected to benefit from both domestic supply-side policies and international market dynamics, with Chinese companies poised to fill gaps in the global supply chain [6] - The focus on sectors with significant profit elasticity, such as pesticides and organic silicon, is recommended, alongside attention to potassium and phosphorus chemical industries amid a potential interest rate cut by the Federal Reserve [6]

Core Insights - The article highlights the significant net inflow of main funds into specific stocks over a period of five days or more, indicating strong investor interest and potential growth opportunities in these companies [1][2] Group 1: Key Stocks with Net Inflows - Cambrian Biologics-U (688256) leads with a continuous net inflow for 30 days, totaling 4.192 billion CNY, with a price increase of 41.87% [1] - Huayou Cobalt (603799) follows with a net inflow of 1.829 billion CNY over five days, reflecting a 25.57% increase [1] - Zhongnan Media (601098) has seen a net inflow for eight days, amounting to 1.111 billion CNY, with a minimal price change of 0.16% [2] Group 2: Notable Inflow Metrics - The highest net inflow percentage relative to trading volume is observed in Hebang Biology (603077), with a 13.89% ratio and a price increase of 8.90% over five days [1] - The total net inflow for Cambrian Biologics-U over 30 days is 4.192 billion CNY, indicating strong market confidence [1] - Other notable stocks include Tianqi Lithium (002466) with a net inflow of 576 million CNY and a price increase of 11.09% [1]

证券之星消息，9月30日农化制品板块较上一交易日上涨1.86%，蓝丰生化领涨。当日上证指数报收于 3882.78，上涨0.52%。深证成指报收于13526.51，上涨0.35%。农化制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002513 | 蓝丰生化 | 10.40 | 10.05% | 42.34万 | | 4.38亿 | | 603810 | 丰山集团 | 17.28 | 9.99% | 10.27万 | | · 1.76亿 | | 603077 | 和邦生物 | 2.08 | 6.67% | 520.46万 | | 10.90亿 | | 002895 | 川恒股份 | 29.26 | 5.03% | 22.30万 | | 6.45亿 | | 600141 | 兴发集团 | 28.17 | 3.38% | 25.35万 | | 7.06亿 | | 000792 | 盐湖股份 | 20.85 | 3.17% | 88.65万 | | 18.37亿 ...